Back
Biodexa Pharmaceuticals Plc Quote, Financials, Valuation and Earnings
Sell
47
BDRX
Biodexa Pharmaceuticals Plc
Last Price:
1.18
Seasonality Move:
-17.41%
7 Day Trial
ALL ACCESS PASS
$
7
Biodexa Pharmaceuticals Plc Price Quote
$1.18
-0.01 (-4.84%)
(Updated: May 18, 2024 at 5:38 AM ET)
Biodexa Pharmaceuticals Plc Key Stats
Sell
47
Biodexa Pharmaceuticals Plc (BDRX)
is a Sell
Day range:
$1.16 - $1.37
52-week range:
$0.67 - $17.60
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.73
P/B ratio:
0.88%
Volume:
480.8K
Avg. volume:
2.7M
1-year change:
-93.53%
Market cap:
$5.2M
Revenue:
$474.1K
EPS:
$-402
How Much Does Biodexa Pharmaceuticals Plc Make?
-
How Much Are Biodexa Pharmaceuticals Plc's Sales Annually?
BDRX Revenues are $474.1K -
How Much Profit Does Biodexa Pharmaceuticals Plc's Make A Year?
BDRX net income is -$8.8M
Is Biodexa Pharmaceuticals Plc Growing As A Company?
Data Unavailable
Biodexa Pharmaceuticals Plc Stock Price Performance
-
Did Biodexa Pharmaceuticals Plc Stock Go Up Last Month?
Biodexa Pharmaceuticals Plc share price went up by 39.92% last month -
Did BDRX's Share Price Rise Over The Last Year?
BDRX share price fell by -93.53% over the past 1 year
What Is Biodexa Pharmaceuticals Plc 52-Week High & Low?
-
What Is Biodexa Pharmaceuticals Plc’s 52-Week High Share Price?
Biodexa Pharmaceuticals Plc has traded as high as $17.60 over the past 52 weeks -
What Is Biodexa Pharmaceuticals Plc’s 52-Week Low Share Price?
Biodexa Pharmaceuticals Plc has traded as low as $0.67 over the past 52 weeks
Biodexa Pharmaceuticals Plc Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Biodexa Pharmaceuticals Plc?
-
How Much Debt Does Biodexa Pharmaceuticals Plc Have?
Total long term debt quarterly is $0 -
How Much Cash Does Biodexa Pharmaceuticals Plc Have?
Cash and short term investments quarterly total is $7.6M -
What Is Biodexa Pharmaceuticals Plc’s Book Value Per Share?
Book value per share is 2.00
Is Biodexa Pharmaceuticals Plc Cash Flow Positive?
-
What Is BDRX Cash Flow From Operations?
Cash flow from operations (TTM) is -$8.5M -
What Is Biodexa Pharmaceuticals Plc’s Cash Flow From Financing?
Cash flow from financing (TTM) is $12.8M -
What Is Biodexa Pharmaceuticals Plc’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$328.9K
Biodexa Pharmaceuticals Plc Return On Invested Capital
-
Is Management Doing A Good Job?
BDRX return on invested capital is -160.77% -
What Is Biodexa Pharmaceuticals Plc Return On Assets?
ROA measures how assets are converting to revenues and is -87.8% -
What Is BDRX Return On Equity?
ROE is a measure of profitability and is -160.77%
Biodexa Pharmaceuticals Plc Earnings Date & Stock Price
-
What Is Biodexa Pharmaceuticals Plc's Stock Price Today?
A single share of BDRX can be purchased today for 1.19 -
What Is Biodexa Pharmaceuticals Plc’s Stock Symbol?
Biodexa Pharmaceuticals Plc trades on the nasdaq under the ticker symbol: BDRX -
When Is Biodexa Pharmaceuticals Plc’s Next Earnings Date?
The next quarterly earnings date for Biodexa Pharmaceuticals Plc is scheduled on August 15, 2024 -
When Is BDRX's next ex-dividend date?
Biodexa Pharmaceuticals Plc's next ex-dividend date is May 19, 2024 -
How To Buy Biodexa Pharmaceuticals Plc Stock?
You can buy Biodexa Pharmaceuticals Plc shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Biodexa Pharmaceuticals Plc Competitors
-
Who Are Biodexa Pharmaceuticals Plc's Competitors?
Below is a list of companies who compete with Biodexa Pharmaceuticals Plc or are related in some way:
Biodexa Pharmaceuticals Plc Dividend Yield
Data Unavailable
Biodexa Pharmaceuticals Plc Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 8.00 |
Upside from Last Price: | 572.36% |